Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Imaging Biomarkers in the Management of Retinal Diseases: Clinical Applications and Future Directions.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: August 19, 2026
Diabetic retinal disease: Five trials to watch.
Journal: Med (New York, N.Y.)
Published: April 13, 2026
An update on the port delivery system with ranibizumab for retinal diseases.
Journal: Expert opinion on drug delivery
Published: April 06, 2026
Visual and Anatomic Outcomes of Faricimab in Naïve Neovascular Age-Related Macular Degeneration with Subretinal Hemorrhage: A Multi-Centre Retrospective Analysis.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: December 17, 2025
Real-World Outcomes in Eyes With Neovascular AMD Switched From Brolucizumab to Faricimab: A TRUCKEE Study Analysis.
Journal: American journal of ophthalmology
Published: July 03, 2025
Reply to Comment on: Subretinal Gene Therapy for Treatment of Retinal and Choroidal Vascular Diseases.
Journal: American journal of ophthalmology
Published: January 10, 2025
The Safety of Recently Approved Therapeutics in Age-Related Macular Degeneration.
Journal: International ophthalmology clinics
Published: December 23, 2024
Subretinal Gene Therapy for Treatment of Retinal and Choroidal Vascular Diseases.
Journal: American journal of ophthalmology
Published: September 03, 2024
Approved treatments for neovascular age-related macular degeneration: current safety and future directions.
Journal: Expert opinion on drug safety
Published: August 05, 2024
Review of Gene Therapy Clinical Trials for Retinal Diseases.
Journal: International ophthalmology clinics
Published: December 26, 2023
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results.
Journal: Eye (London, England)
Published: March 11, 2023
Last Updated: 09/26/2026